Gendius' mission is to make sure every person with diabetes understands their risk of complications and how to manage them. 8.5% of the world's population have diabetes and this can lead to blindness, kidney failure and amputation and increase the risk of a heart attack or stroke.
We have been working with patients and clinicians to develop intellin, an app that takes an individual's clinical history and tells them their risk of developing complications from their diabetes and how to manage these.
Our mission is to ensure that every person with diabetes understands their risk of complications and how to manage them.
The NHS alone spends over £11 billion a year on diabetes & 80% of these costs are avoidable and linked to the complications. The personal impact of diabetes is huge with the disease leading to; blindness, kidney failure, amputation, heart attack and/or stroke.
The number of adults living with diabetes has almost quadrupled since 1980 to 422 million adults and this will reach 629 million by 2045.
We have a B2B2C offering where we will access the NHS via the NHS app store and through pilots with GP practices. The B2C offering will be via a monthly charge on the app stores.
2017 - won part of £500K Innovate award for a clinical trial at Salford Royal NHS Foundation Trust
2017 - recieved £490K VC backing from Catapult Ventures
2017 - won £60K SBRI award for research into gestational diabetes
2018 - won £25K Momentum award to complete UX/UI research
2019 - passed ISO27001
2019 - First NHS pilot
2019 - Over 3500 downloads in UK & EU
2019 - invited to HIMSSHealth2.0 conference for a live demo of the app & 1 of 8 companies invited to pitch to investors